UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort Journal article
Tang, Liang Jie, Sun, Dan Qin, Song, Sherlot Juan, Yip, Terry Cheuk Fung, Wong, Grace Lai Hung, Zhu, Pei Wu, Chen, Sui Dan, Karsdal, Morten, Leeming, Diana Julie, Jiang, Pei, Wang, Cong, Chen, Qiang, Byrne, Christopher D., Targher, Giovanni, Eslam, Mohammed, George, Jacob, Wong, Vincent Wai Sun, Zheng, Ming Hua. Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort[J]. Liver International, 2024, 44(5), 1129-1141.
Authors:  Tang, Liang Jie;  Sun, Dan Qin;  Song, Sherlot Juan;  Yip, Terry Cheuk Fung;  Wong, Grace Lai Hung; et al.
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:6.0/6.3 | Submit date:2024/05/16
Chronic Kidney Disease  Liver Fibrosis  Metabolic Dysfunction-associated Fatty Liver Disease  Metabolic Dysfunction-associated Steatotic Liver Disease  N-terminal Propeptide Of Type 3 Collagen  Risk Prediction  
The protective effect of hyperoside on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2 Journal article
Zou, Liyi, Chen, Shaoru, Li, Li, Wu, Tie. The protective effect of hyperoside on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2[J]. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2017, 69(7), 451-460.
Authors:  Zou, Liyi;  Chen, Shaoru;  Li, Li;  Wu, Tie
Favorite | TC[WOS]:37 TC[Scopus]:41  IF:2.023/2.148 | Submit date:2018/10/30
Hyperoside  Chronic Liver Fibrosis  Oxidative Stress  Nrf2